The FDA has cleared the first lab diagnostic test to aid in the early detection of Alzheimer's disease.
May 5, 2022 – The FDA has cleared the first in vitro diagnostic to aid in the early detection of Alzheimer's disease .
"With the Lumipulse test, there is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status, without the radiation risk, to help determine if a patient's cognitive impairment is due to Alzheimer's disease," he said. The Lumipulse test measures the ratio of β-amyloid 1-42 and β-amyloid 1-40 concentrations in human cerebral spinal fluid . A positive Lumipulse G β-amyloid Ratio test result is consistent with the presence of amyloid plaques, similar to that revealed in a PET scan. A negative result is consistent with a negative amyloid PET scan result.
The samples were tested by the Lumipulse G β-amyloid Ratio and compared with amyloid PET scan results. In this clinical study, 97% of individuals with Lumipulse G β-amyloid Ratio positive results had the presence of amyloid plaques by PET scan and 84% of individuals with negative results had a negative amyloid PET scan.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
A drug firm in Bucks County that sold FDA-approved generics had big plans to grow. Now it faces charges of misleading the FDADaily News | A drug firm in Bucks County that sold FDA-approved generics had big plans to grow. Now it faces charges of misleading the FDA
Les mer »
FDA Approves Nonstimulant ADHD Medication Qelbree for Adult UseThe first nonstimulant ADHD medication approved by the FDA for adult use in two decades, Qelbree (Viloxazine) achieved positive results in a randomized, double-blind, placebo-controlled Phase 3 study.
Les mer »
FDA Officials Say Annual Covid-19 Shots May Be Needed In The FutureThe United States might need to update its Covid-19 vaccines each year, according to a trio of top US Food and Drug Administration officials, and 'a new normal' may include an annual Covid-19 vaccine alongside a seasonal flu shot.
Les mer »
Vaxxinity vaccine to treat Alzheimer’s wins FDA fast-track designationMultiple vaccines in the Dallas biotech company’s platform made significant regulatory progress in the last month.
Les mer »
FDA Warns of Counterfeit Home COVID Test KitsThe FDA warns Americans to watch out for phony at-home, over-the-counter COVID tests that look a lot like the real things.
Les mer »
So, There’s Lead In Your Juice—and the FDA Is Trying to Lower the AmountHow it got there in the first place is even more interesting.
Les mer »